- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06958172
- Original Trial
The Effects of Core Stabilization on Desk Workers With Postural Disorders (CORE)
May 2, 2025 updated by: Muhammed ARCA, Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Investigation of The Effects of Core Stabilization, Hip and Thoracic Mobility Exercises on Desk Workers With Postural Disorders
This study aimed to investigate the effects of core, thoracic and hip mobility exercises on trunk stabilization and postural improvement in desk workers with postural disorders.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
A randomized controlled study was conducted with 40 desk workers aged 25-45.
Participants were divided into two groups: Study Group (n=21) and Control Group (n=20).
Participants in the Study Group received core stabilization, thoracic Participants in the Control Group performed mobility and hip mobility exercises, while participants in the Control Group only performed the same home exercise program.
Before and after treatment, trunk stabilization of the participants was evaluated with the Plank test and Sorenson test, and their balance was evaluated with the Y balance test .
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Muhammed ARCA, Dr
- Phone Number: 05342673023
- Email: muhammed.arca@sbu.edu.tr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Having a desk job
- Being between the ages of 25-45,
- Written approval of participation in the study by himself/herself or his/her legal representative
Exclusion Criteria:
- Having had surgery within the last six months,
- Having a previously identified and diagnosed cardiovascular or pulmonary disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
only performed the same home exercise program
|
|
|
Experimental: Other
Exercise
|
Study Group received core stabilization, thoracic mobility and hip mobility exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment Methods
Time Frame: 2 months
|
Participants' trunk stabilization with Plank-Sorenson and Y Balance Test will be assessed before and after treatment.
|
2 months
|
|
Plank test and Sorenson test
Time Frame: 2 months
|
It is one of the basic static tests used to measure trunk endurance.
Subjects are asked to lie face down, stand on their toes with their forearms and elbows shoulder-width apart and their pelvis lifted, and their neck, shoulders, back, hips and legs forming a straight line parallel to the ground, and the subject is asked to maintain this posture.
The time until the subject gets tired and/or breaks their posture is recorded in seconds from the start of the time
|
2 months
|
|
Y balance test
Time Frame: 2 months
|
Y Balance Test" platform was used to measure dynamic postural control .
The leg length of each participant was measured in centimeters in the supine position bilaterally and anteriorly.
medial from superioriliac point Malleolus The measurements were recorded by measuring the distal part.
The measurements were tested barefoot, in 3 directions, anterior (ANT) reach as the distance between the participant's central toe tip, and posterolateral (PL) and posteromedial (PM) reach as the farthest point from the heel.
During the trial, the participants are asked to keep their hands on the iliac crest and their heels on the floor and to lightly touch the farthest point with the toe tip of the reaching foot. in order to eliminate the leg length advantage, the scores obtained were normalized using the formula "Best Reach Distance/Leg Length ) x100 = % maximum reach distance" for each direction
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Mertcan Kızılpınar, Istinye University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 25, 2025
Primary Completion (Estimated)
June 25, 2025
Study Completion (Estimated)
June 25, 2025
Study Registration Dates
First Submitted
March 13, 2025
First Submitted That Met QC Criteria
May 2, 2025
First Posted (Actual)
May 6, 2025
Study Record Updates
Last Update Posted (Actual)
May 6, 2025
Last Update Submitted That Met QC Criteria
May 2, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Istinye University
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Due to confidentiality of patient data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.